BusinessTempus Launches Tempus xE, Whole Exome Sequencing to Empower Data-Driven Cancer Care and ResearchBy Nasdaq OMXFeb 22, 2018, 3:30 PM UTC
BusinessStratos Genomics Raises Funds to Ready for CommercializationBy Nasdaq OMXJan 8, 2018, 3:00 PM UTC
BusinessFluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno SystemBy Nasdaq OMXAug 17, 2017, 8:05 PM UTC
BusinessFluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in ChinaBy Nasdaq OMXJul 27, 2017, 8:05 PM UTC
BusinessUniversity of Rochester School of Medicine and Dentistry Collaborate with Admera Health in a Clinical Study, Evaluating Pharmacogenomics in Acute Surgical Pain ManagementBy Nasdaq OMXMay 9, 2017, 1:13 PM UTC
